Frank Oliver Nestle

Frank Oliver Nestle's AcademicInfluence.com Rankings

Frank Oliver Nestle

Medical

#2276

World Rank

#2689

Historical Rank

Oncology

#132

World Rank

#136

Historical Rank

medical Degrees

Frank Oliver Nestle

Biology

#9002

World Rank

#12156

Historical Rank

Immunology

#528

World Rank

#545

Historical Rank

biology Degrees

Download Badge

Medical
Biology

Frank Oliver Nestle's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Frank Oliver Nestle Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Frank Oliver Nestle's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells (1998) (3018)
Mechanisms of Disease: Psoriasis. (2009) (1796)
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide (2007) (1680)
Skin immune sentinels in health and disease (2009) (1150)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production (2005) (1010)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial (2005) (1002)
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. (2009) (1000)
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) (947)
Mapping cis- and trans-regulatory effects across multiple tissues in twins (2012) (754)
Mechanisms regulating skin immunity and inflammation (2014) (648)
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. (2010) (642)
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (2012) (555)
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. (2004) (543)
Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α (2004) (497)
Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. (1993) (473)
The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study (2011) (460)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. (2006) (457)
Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis (2007) (429)
Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. (2011) (422)
Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity (2012) (397)
Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation (2017) (395)
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. (2004) (374)
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. (2002) (368)
Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis (2013) (329)
Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells (2011) (324)
Dendritic cells: On the move from bench to bedside (2001) (322)
Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis (2011) (294)
The multitasking organ: recent insights into skin immune function. (2011) (293)
Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. (1994) (285)
Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. (2010) (277)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans (2011) (257)
Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions (2014) (253)
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation (2012) (238)
Gene expression changes with age in skin, adipose tissue, blood and brain (2013) (237)
The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis (2015) (232)
Dendritic-cell-based therapeutic vaccination against cancer. (2005) (221)
Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis (2010) (220)
TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis (2013) (219)
Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium (2016) (218)
α1β1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis (2007) (206)
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. (2008) (205)
Dendritic cells up‐regulate immunoproteasomes and the proteasome regulator PA28 during maturation (1999) (198)
Increased metal allergy in patients with failed metal‐on‐metal hip arthroplasty and peri‐implant T‐lymphocytic inflammation (2009) (186)
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). (1996) (185)
The cytokine and chemokine network in psoriasis. (2007) (181)
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. (1997) (180)
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. (2008) (166)
Human dendritic cells phagocytose and process Borrelia burgdorferi. (1996) (165)
Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. (1995) (163)
Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype (2012) (157)
A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. (1991) (153)
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 (2003) (151)
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration (2014) (150)
The pathogenic role of tissue-resident immune cells in psoriasis. (2007) (148)
Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. (2007) (148)
Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. (2004) (147)
Metallurgy: High nickel release from 1- and 2-euro coins (2002) (145)
Microbe-host interplay in atopic dermatitis and psoriasis (2019) (142)
The IL-23/IL-17 axis in psoriatic arthritis. (2014) (141)
Differential methylation of the TRPA1 promoter in pain sensitivity (2014) (133)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. (2003) (132)
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. (2002) (128)
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate‐to‐severe psoriasis: a randomized controlled trial (2006) (126)
A role for Th17 cells in the immunopathogenesis of atopic dermatitis? (2008) (122)
Biomarkers in psoriasis and psoriatic arthritis (2013) (120)
Targeting CD8(+) T cells prevents psoriasis development. (2016) (109)
MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution. (1997) (104)
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells (2009) (103)
Immunopathogenesis of Psoriasis (2007) (102)
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment (2019) (99)
Innate and adaptive immune traits are differentially affected by genetic and environmental factors (2017) (96)
Pityriasis rosea is not associated with human herpesvirus 7. (1999) (96)
IgG4 subclass antibodies impair antitumor immunity in melanoma. (2013) (94)
Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. (2015) (93)
TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination (2015) (92)
Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis (2003) (91)
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. (1994) (90)
Nephrogenic Fibrosing Dermopathy Treated with Extracorporeal Photopheresis (2004) (88)
Harnessing dendritic cells in inflammatory skin diseases (2011) (88)
Human dermal dendritic cells process and present soluble protein antigens. (1998) (88)
Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. (2003) (88)
Progress in understanding the immunopathogenesis of psoriasis. (2009) (86)
The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging. (2015) (82)
Immunogenicity of biotherapy used in psoriasis: the science behind the scenes. (2015) (81)
IgG4 subclass antibodies impair antitumor immunity in melanoma (2013) (80)
TAP1 down‐regulation in primary melanoma lesions: An independent marker of poor prognosis (2001) (78)
Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. (1994) (75)
Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma (2014) (74)
Defining upstream elements of psoriasis pathogenesis: an emerging role for interferon alpha. (2005) (73)
Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity (2012) (72)
Dendritic cell vaccination for cancer therapy (2000) (70)
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? (1995) (69)
Revisiting the role of B cells in skin immune surveillance. (2015) (68)
The role of IL-23 in the immunopathogenesis of psoriasis (2010) (68)
IgG4 Characteristics and Functions in Cancer Immunity (2016) (67)
New perspectives on immunobiology and immunotherapy of melanoma. (1999) (66)
Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants (2015) (66)
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. (1996) (64)
Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies (2011) (63)
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. (2003) (60)
Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. (2001) (60)
A Systems Model for Immune Cell Interactions Unravels the Mechanism of Inflammation in Human Skin (2010) (60)
Transcriptome classification reveals molecular subtypes in psoriasis (2012) (59)
Direct and indirect control of T-cell activation by keratinocytes. (1995) (59)
Conditional analysis identifies three novel major histocompatibility complex loci associated with psoriasis. (2012) (58)
A fresh morphological and functional at dermal dendritic cells (1995) (57)
Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept (2002) (56)
Unraveling the autoimmune translational research process layer by layer (2012) (55)
Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies (2014) (54)
The IL-12 family member p40 chain as a master switch and novel therapeutic target in psoriasis. (2004) (54)
The IL23R A/Gln381 Allele Promotes IL-23 Unresponsiveness in Human Memory T-Helper 17 Cells and Impairs Th17 Responses in Psoriasis Patients (2013) (51)
Deepening our understanding of immune sentinels in the skin. (2007) (50)
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper (2015) (49)
Pathology of cutaneous T-cell lymphoma. (1995) (49)
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application (2012) (48)
Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7– T lymphocyte subsets in Sézary syndrome (1999) (47)
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling. (2017) (47)
Unraveling Vascular Inflammation: From Immunology to Imaging. (2017) (46)
Treatment of Verrucous Carcinoma with Imiquimod and CO2 Laser Ablation (2003) (46)
Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer (2018) (46)
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma (2015) (45)
The αvβ5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses (2003) (44)
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin (2016) (41)
Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? (1992) (41)
A fresh morphological and functional look at dermal dendritic cells. (1995) (40)
An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element (2013) (39)
From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. (2002) (38)
Formation of neutralizing antibodies against natural interferon‐β, but not against recombinant interferon‐γ during adjuvant therapy for high‐risk malignant melanoma patients (1991) (38)
Autologous dendritic cells for treatment of advanced cancer--an update. (2001) (37)
Dermal dendritic cells are important members of the skin immune system. (1995) (37)
Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis (2014) (35)
The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. (2003) (35)
Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7. (1994) (34)
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI‐mediated basophil activation by a tumour‐specific IgE antibody to evaluate the risk of type I hypersensitivity (2011) (34)
Expression of cancer/testis antigens in cutaneous T cell lymphomas (2002) (33)
Cutaneous malignant lymphomas: Update 2006 (2006) (33)
T Lymphocytes in Skin Lesions of Psoriasis and Mycosis Fungoides Express B7-1: A Ligand for CD28 (1994) (33)
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy. (2015) (33)
T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28. (1994) (32)
Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. (2007) (31)
T Cell–Independent Mechanisms Associated with Neutrophil Extracellular Trap Formation and Selective Autophagy in IL-17A–Mediated Epidermal Hyperplasia (2016) (29)
Leukocyte extravasation as a target for anti‐inflammatory therapy – Which molecule to choose? (2005) (29)
Dendritic cell-based cancer therapy. (2003) (29)
Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn? (2017) (28)
Allele-specific cytokine responses at the HLA-C locus, implications for psoriasis (2011) (28)
Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. (1999) (28)
From classical mouse models of psoriasis to a spontaneous xenograft model featuring use of AGR mice. (2005) (27)
PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells (2016) (27)
Vaccination of melanoma patients with peptide-pulsed dendritic cells: 047 (1997) (27)
Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas (1991) (27)
Multilesional Primary Cutaneous Diffuse Large B-Cell Lymphoma Responsive to Antibiotic Treatment (2001) (27)
IgG4 antibodies and cancer-associated inflammation (2013) (26)
Mechanisms of psoriasis (2004) (26)
Cocaine-Related Stevens-Johnson Syndrome (2000) (26)
Clinical Efficacy of Narrow-Band UVB (311 nm) Combined with Dithranol in Psoriasis (2000) (26)
CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway (2020) (26)
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy. (2009) (25)
Skin resident memory CD8+ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function (2018) (25)
Role of dendritic cells in benign and malignant lymphocytic infiltrates of the skin. (1994) (25)
An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE (2018) (24)
T‐cell receptor β variable region (Vβ) usage in cutaneous T‐cell lymphomas (CTCL) in comparison to normal and eczematous skin (1996) (23)
[Systemic therapy of metastatic melanoma]. (1999) (23)
Current State and Perspectives of Dendritic Cell Vaccination in Cancer Immunotherapy (2006) (22)
Monoclonal Rearrangement of the T Cell Receptor Gamma-Chain in Lichenoid Pigmented Purpuric Dermatitis of Gougerot-Blum Responding to Topical Corticosteroid Therapy (2002) (22)
High Frequency of Melanoma-Associated Antigen or HLA Class I Loss Does Not Correlate with Survival in Primary Melanoma (2004) (22)
An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples (2019) (21)
Dendritic cell vaccination for cancer therapy (2001) (21)
Cancer Vaccines: The Next Generation of Tools to Monitor the Anticancer Immune Response (2005) (20)
Progress in Understanding the Immunopathogenesis of Psoriasis (2009) (20)
Integration of Lyoplate Based Flow Cytometry and Computational Analysis for Standardized Immunological Biomarker Discovery (2013) (19)
Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study. (2004) (19)
Polypropylene Sulfide Nanoparticle p24 Vaccine Promotes Dendritic Cell-Mediated Specific Immune Responses against HIV-1. (2016) (18)
Animal models of psoriasis and psoriatic arthritis: An update (2006) (18)
Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis (2002) (18)
Translational drug discovery and development with the use of tissue‐relevant biomarkers: Towards more physiological relevance and better prediction of clinical efficacy (2020) (16)
Occupational dermatoses in cheese makers: frequent association of irritant, allergic and protein contact dermatitis. (1997) (16)
Predictive immunomonitoring -- the COST ENTIRE initiative. (2013) (15)
Microbial and transcriptional differences elucidate atopic dermatitis heterogeneity across skin sites (2020) (15)
Extracorporeal photochemotherapy for Epstein-Barr virus-associated lymphoma after lung transplantation. (1999) (14)
Bilateral Carpal Tunnel Syndrome as a Clue for the Diagnosis of Systemic Amyloidosis (2001) (13)
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells (2018) (12)
γ/δ Receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis (1992) (12)
Advances in the treatment of melanoma. (2012) (12)
Practical guidance on immunogenicity to biologic agents used in the treatment of psoriasis: What can be learnt from other diseases? (2015) (10)
Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. (1991) (10)
Cultured Kaposi's sarcoma tumor cells fail to stimulate T cell proliferation. (1996) (10)
Pharmacokinetics of 8‐methoxypsoralen during extracorporeal photopheresis (1999) (10)
T-cell phenotyping uncovers systemic features of atopic dermatitis and psoriasis. (2019) (10)
The mechanistic basis for psoriasis immunopathogenesis: translating genotype to phenotype. Report of a workshop, Venice, 2012 (2013) (9)
Functional detection of epithelial cell adhesion molecule specific cytotoxic T lymphocytes in patients with lung cancer, colorectal cancer and in healthy donors. (2002) (9)
What on "irf" is this gene 4? Irf4 transcription-factor-dependent dendritic cells are required for T helper 2 cell responses in murine skin. (2013) (9)
Cell type classification and discovery across diseases, technologies and tissues reveals conserved gene signatures and enables standardized single-cell readouts (2021) (9)
Toward prediction of immune mechanisms and design of immunotherapies in melanoma. (2012) (9)
T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. (1996) (9)
[Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. (2001) (8)
IgE Interacts with Potent Effector Cells Against Tumors: ADCC and ADCP (2010) (8)
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis (2020) (8)
[Current therapy concepts in cutaneous T-cell lymphomas]. (1997) (7)
Distinct subtypes of subcutaneous T-cell lymphoma. (1994) (7)
Pathway-level disease data mining through hyper-box principles. (2015) (7)
Human herpesvirus 7 and Pityriasis rosea (1998) (6)
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis (2022) (6)
Real-Time Polymerase Chain Reaction Monitoring of Epithelial Cell Adhesion Molecule-Induced T-Cell Stimulation in Patients With Lung Cancer and Healthy Individuals Using LightCycler Technology (2002) (6)
Fundamentals of Inflammation: Inflammatory Skin Diseases (2010) (5)
Melanoma vaccines in development: looking to the future. (2000) (5)
Soluble interleeukin‐2 receptors and cutaneous t‐cell lymphoma (1993) (5)
[Case report on therapy with granulocyte stimulating factor in diabetic foot]. (2001) (5)
Functional expression of the eotaxin receptor CCR 3 in CD 30 positive cutaneous T cell lymphoma (2002) (5)
Sensitization and Development of Allergic Contact Dermatitis Caused by a Single Contact with an Electrosurgical Grounding Plate Containing Acrylates (1998) (4)
[Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. (2000) (4)
A new lease on life for dendritic cell vaccines? (2006) (4)
Conversion of uninvolved to involved psoriatic skin transplanted onto AGR mice indicates intrinsic default pathway of psoriasis disease pathogenesis (2002) (3)
Infliximab produces a sustained and significant improvement in psoriasis over 50 weeks of continuous therapy. (2005) (3)
Dendritic cell vaccination for the treatment of skin cancer. (2002) (3)
Interleukin-10-producing B-cell populations in melanoma (2012) (3)
Generation of blood-derived human dendritic cells for antitumor immunotherapy. (2001) (3)
Vaccination with Dendritic Cells - A Specific Immunomodulatory Approach for the Treatment of Malignant Melanoma (1997) (3)
Targeted Therapies and Biomarkers for Personalized Treatment of Psoriasis (2015) (3)
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression (2022) (3)
Therapy for cutaneous melanoma (1998) (3)
Disease Classification through Integer Optimisation (2011) (3)
Infliximab safety experience: Data from clinical trials in patients with psoriatic disease (2006) (3)
Gene expression changes with age in skin, adipose tissue, blood and brain (2013) (2)
Cancers of the Skin (2002) (2)
Functional expression of CCR3 but not of CCR7 in lymphogenic melanoma metastasis (2002) (2)
Chemokines and their receptors in psoriasis. (2002) (2)
VLA-1 dependent intraepidermal T cell expansion is necessary for the development of psoriasis (2004) (2)
F.15. A Gene-to-Function Analysis of IL-23R Arg381Gln Polymorphism Reveals Impaired IL-17A Production in Th17 Cells (2009) (2)
Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. (2002) (2)
[Cytokine-producing lymphoma T cells in the skin and peripheral blood associated with atopy and hypereosinophilia]. (1999) (2)
[Immunotherapy of melanoma]. (2000) (2)
Dendritic cell therapy for skin cancer (2004) (2)
A novel skin-resident vitamin D-3-inducible human dendritic cell playing a critical role in tissue h (2012) (2)
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis (2023) (2)
IgE immunotherapy of solid tumours: a novel model targeting folate receptor alpha (FR alpha)-positiv (2011) (1)
Transcriptome modelling of psoriatic lesions to identify and subsequently characterize novel targets in cutaneous inflammation (2008) (1)
New treatment with granulocyte-colony stimulating factor in diabetic foot ulceration (2001) (1)
Identification of a novel pro-inflammatory human skin-homing V gamma 9V delta 2 T cell subset and its role in the pathogenesis of psoriasis (2011) (1)
The R381Q variant of the interleukin-23 receptor gene (IL23R) confers protection against psoriasis vulgaris (2007) (1)
Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. (2001) (1)
Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function (2022) (1)
Skin resident CD8(+) T-cells display low cytotoxic potential in healthy skin and fail to fully mature in primary melanoma lesions (2014) (1)
Cancers of the skin. Proceedings of the 8th World Congress on Cancers of the Skin, Zurich, Switzerland, 18th-21st July 2001. (2002) (1)
A successful therapeutic model for psoriasis: recapitulation of human psoriasis in a xenotransplantation mouse model (2009) (1)
02 High frequency of allelic deletion on 9p21 (p16 gene locus) in melanoma metastases of non-responders to peptide-pulsed dendritic cell vaccination (1999) (1)
Metal Implant Allergy (2012) (1)
B Lymphocytes Accumulate and Proliferate in Human Skin at Sites of Cutaneous Antigen Challenge (2021) (1)
Demonstration of novel innate immune cells in psoriasis (2010) (1)
Characterization of ZNF313/RNF114 as a novel psoriasis susceptibility gene (2008) (1)
Publisher Correction: An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples (2020) (1)
Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress (2020) (1)
Erratum: Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants (2015) (1)
Functional dissection of interleukin-17 in the pathogenesis of psoriasis (2007) (1)
An essential functional role for epidermal T cells in the development of psoriasis (2006) (1)
[Vaccination therapy of malignant melanoma]. (1999) (1)
Erratum: Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose? (Experimental Dermatology (2005) vol. 14 (70-80)) (2005) (1)
Transcriptome classification reveals molecular subtypes in psoriasis (2012) (1)
Wellcome Trust Functional Genomics and Systems Biology Workshop (2009) (1)
[Concepts for immune intervention in psoriasis vulgaris]. (2000) (1)
[Modern tumor therapy as seen in melanoma]. (1996) (1)
Characterization of antibody responses in malignant melanoma (2010) (1)
Dendritic Cells and Cancer: Prospects for Cancer Vaccination (2003) (1)
TNF-alpha-dependent induction of psoriasis in the absence of pymphocyte-recruitment. (2002) (1)
Identification of a novel skin homing V gamma 9V delta 2 T cell subset and its potential implication in the immunopathogenesis of psoriasis (2009) (0)
7 Specific immunotherapy for melanoma: pitfalls and perspectives (1999) (0)
with a Potential Role in Psoriasis2 T Cell Subset d 9V g Human Skin-Homing V Identification of a Novel Proinflammatory (2011) (0)
Anti-HMW-MAA IgE antibodies (2011) (0)
Contents Vol. 202, 2001 (2001) (0)
Human circulating B cells express skin-homing receptors and accumulate within the skin at sites of infectious and neoplastic inflammation (2014) (0)
Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. (1993) (0)
Phenotypic and functional characterization of a novel subset of skin-resident regulatory CD141(+) DCs that spontaneously produce high levels of IL-10 (2010) (0)
The IL23R R381Q gene variant protects against psoriasis by impairing IL-23-induced STAT-3 phosphorylation and IL-17A production in human Th17 cells (2011) (0)
Publisher Correction: An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples (2020) (0)
Blockade of VLA-2, (alpha2beta1 integrin) inhibits psoriasis in a T-cell-independent manner (2006) (0)
Expression of CD1 family molecules in primary and metastatic melanoma (2001) (0)
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4 (2023) (0)
Identification of novel CD22- B cell subsets in melanoma with potential anti-tumour effects (2013) (0)
Keyhole Limpet Hemocyanin (KLH)-pulsed dendritic cells induce longterm Th1-type immune response in patients with metastatic melanoma (1998) (0)
Genes and pathways in inflammatory diseases (SY6-5) Chairpersons: Kouji Matsushima, Virginia Pascual (2010) (0)
IgE anti-HMW-MAA antibody: PCT/GB2011/051884 (2013) (0)
Subject Index Vol. 190,1995 (1995) (0)
Lymphocytes in Skin Lesions of Psoriasis and Mycosis Fungoides Express B 7-1 : A Ligand for CD 28 (2000) (0)
A novel skin-resident vitamin D3 inducible CD141(+) human dendritic cell playing a critical role in tissue homeostasis and immunoregulation (2012) (0)
Cheese Makers (2019) (0)
Melanoma Vaccines in Development (2000) (0)
Cancer and IgE (2010) (0)
Abstract 2524: Antibodies of the IgG and IgE classes against the melanoma-associated antigen HMW-MAA: Investigating a new therapeutic approach (2012) (0)
Unraveling Vascular Inflammation (0)
Abstract B46: Immunotherapy of solid tumors with IgE antibodies: Paradigm of a novel concept towards clinical application. (2013) (0)
The immunoregulatory role of B lymphocyte populations in malignant melanoma (2011) (0)
Functional evidence for a role of interleukin-23 in the pathogenesis of psoriasis. (2007) (0)
Induction of psoriasis involves TNF alpha production by heat shock protein receptor CD91 expressing antigen presenting cells and is independent on recruitment of lymphocytes (2002) (0)
A CLA-positiv and L-selectin-negativ cutaneous T-cell lymphoma with transition of a skin homing to a lymphnode homing phenotype after treatment with extra-corporeal photopheresis (ECP) (1998) (0)
Cancer of the Skin : Proceedings of the 8th World Congress (2002) (0)
483 Alternative activation of cutaneous B cells and IgG antibody subclass polarisation in melanoma (2016) (0)
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) (2008) (0)
Acknowledgment to Referees for Dermatology 1998 (1998) (0)
Pre-clinical mouse models of human skin transplant rejection, skin immune cell migration, and human melanoma xenografts for the in vivo assessment of novel immunotherapies (2011) (0)
Characterization of a novel skin resident IL-10 producing regulatory dendritic cell subset (2011) (0)
Memory T cells with a skin-homing phenotype in xenogeneic graft-versus-host-disease (2010) (0)
Abstract A116: IgG antibody switching and clonal expansion in melanoma and normal skin microenvironments (2016) (0)
Molecular mechanisms of disease: osteoarthritisI68. Osteoarthritis (2012) (0)
Animal models of T-cell mediated skin diseases. Proceedings of the 50th Ernst Schering Research Foundation Workshop. November 24-26, 2003. Berlin, Germany. (2005) (0)
Lyoplate-based multiparameter flow cytometry for the analysis of T cell subsets in human immuno-monitoring studies (2011) (0)
Whole tissue molecular profiling identifies unique cytokine-related gene sets of disease progression and response to therapy (2012) (0)
Disease subphenotypes based on cytokine-specific molecular signatures: moving towards stratified medicine (2012) (0)
Sa.96. A Novel Vitamin D Analog has a Profound Effect in Generating Potent Immunomodulatory Dendritic Cells (2008) (0)
Evidence for a Role of the Interleukin-23 Pathway in the Pathogenesis of Psoriasis (2007) (0)
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis (2021) (0)
AB0018 TRANSCRIPTOMIC CHARACTERIZATION OF SINGLE PATHOGENIC MEMORY B CELLS IN RHEUMATOID ARTHRITIS (2019) (0)
Antigen-pulsed dendritic cell approach to melanoma. (2001) (0)
A platform for discovery, cloning and expression of melanoma reactive antibodies (2014) (0)
Contents, Vol. 190, 1995 (1995) (0)
NFkB gene family member expression in CTCL skin lesions and IKB downregulation in CTCL cell lines (2001) (0)
Monocyte derived dendritic cells mature in response to the TLR7 agonist loxoribine (2004) (0)
The psoriasis-protective IL23R A/Glu381 allele promotes interleukin-23 unresponsiveness in human memory T helper (Th) 17 cells and impairs Th17 response in patients with psoriasis (2012) (0)
Global circulating CD4+and CD8+T cells are more differentiated in old melanoma patients compared to healthy controls (2013) (0)
Interleukin-32 is overexpressed in psoriasis and regulates keratinocyte-mediated inflammatory responses (2009) (0)
Genome-wide expression profiling of the psoriatic transcriptome (2011) (0)
Subject Index Vol. 202, 2001 (2001) (0)
MicroRNA-146a modulates proinflammatory cytokines in the skin (2012) (0)
Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant checkpoint in psoriatic inflammation (2011) (0)
Present state and future of biologics in autoimmune diseases 1: Cytokines (CS-2) Chairpersons: Josef Smolen, Yoshiya Tanaka (2010) (0)
Su.49. Pleiotropic Susceptibility Loci Identified in Psoriasis, Type II Diabetes and Crohn's Disease (2008) (0)
Investigation of the spatiotemporal expression pattern of the antimicrobial peptide, LL-37, in the development and resolution of psoriasis (2009) (0)
Characterization, regulation and biological effects of IL-17 isoforms involving T cells and keratinocutes in psoriasis. (2007) (0)
Matrix metalloproteinase 11 (MMP11) is elevated in skin and serum from individuals with recessive dystrophic epidermolysis bullosa (RDEB) (2013) (0)
Characterization of peritumoral dendritic antigen-presenting cells (APCs) in sunlight induced skin cancers: 43 (1997) (0)
The role of V gamma 9V delta 2 gamma delta T cells in malignant melanoma (2010) (0)
An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples (2020) (0)
IL-22 is a potential therapeutic target in psoriasis (2011) (0)
Functional analysis of the psoriasis, Crohn's disease and ankylosing spondylitis associated protective R381Q IL23R gene variant reveals impaired Th17 response in humans (2010) (0)
Psoriasis and psoriatic arthritis - Pathogenesis of psoriasis (2005) (0)
OR.59. Investigating the Role of Skin Homing Vγ9Vδ2 T Cells as Novel Pathogenic Cells in Psoriasis (2009) (0)
Antibodies of the IgG4 subclass impaired immune responses against melanoma (2013) (0)
Cultured dermal dendritic cells (DDC) express high levels of B7-2 and their immunostimulatory capacity is reduced by IL-10 (1994) (0)
Genetic and functional evidence for a role of the interleukin 23 pathway in the pathogenesis of psoriasis (2007) (0)
Abstract A009: IgG4: a new tool to predict the risk of disease progression in melanoma (2016) (0)
Immune escape mechanisms in melanoma patients vaccinated with peptide pulsed dendritic cells (1998) (0)
Biomarker discovery in psoriasis using a multiparameter flow cytometry platform (2012) (0)
Analysis of IL12B and IL23R alleles in clinical variants of psoriasis (2008) (0)
Immunpathogenese der Psoriasis vulgaris (1998) (0)
Functional significance of antibody responses impairing antitumour immunity to melanoma (2013) (0)
Cancer/testis antigens in cutaneous T cell lymphomas. (2001) (0)
Discovery and validation of immunological biomarkers using an advanced flow cytometry platform (2010) (0)
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples (2021) (0)
Discovering novel antibodies for melanoma (2010) (0)
Novel approaches to modulate keratinocyte proliferation in psoriasis: in vitro and in silico studies (2010) (0)
Psoriasis and skin diseases (WS-055) Chairpersons: Masayuki Amagai, Akira Takashima (2010) (0)
Immunotherapy of Melanoma Using Dendritic Cells (2000) (0)
Biomarker discovery using integrative systems analysis of whole tissue models (2012) (0)
Advances in the Treatment of Melanoma (1966) (0)
IgE antibodies targeting a major melanoma antigen are more effective than IgG antibodies for tumour protection in a humanized melanoma model (2012) (0)
Innate immune function for HLA-Cw6 in psoriasis: reduced expression of HLA-Cw6 facilitates tumour necrosis factor-alpha release due to impaired interaction with inhibitory receptor KIR2DL1 (2009) (0)
Viewpoint 2 (2005) (0)
Association analysis of the IL12B and IL23R genes in clinical variants of psoriasis (2007) (0)
A bioinformatics approach to analyse whole transcriptome data in psoriasis (2010) (0)
Human CD141+dermal dendritic cells (DCs) and vitamin D3 induced CD141hi DCs are defined by common molecular signatures (2013) (0)
Discovering antibodies for immunotherapy of solid tumours: from the lab bench toward; clinical application (2012) (0)
Vaccination of cutaneous T-cell lymphoma patients with tumor lysate pulsed dendritic cells (2002) (0)
Genetics of autoimmunity (PP-018) (2010) (0)
Faculty Opinions recommendation of A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. (2009) (0)
Biomarkers of skin ageing using genome wide transcriptomics (2011) (0)
Crucial role for intraepidermal T cells expressing the collagen-binding integrin alpha 1 beta 1 in psoriasis (2004) (0)
Shedding of Interleukin-2 Receptor in Cutaneous Lymphomas: An Effective Mechanism to Circumvent Immunosurveillance? (1994) (0)
Delineating relative roles for IFNgamma versus IL-23 in psoriasis using human skin reconstructs. (2007) (0)
Studies of HLA-C expression and regulation using BAC transgenic mice (2010) (0)
Immunization of melanoma patients with peptide-pulsed dendritic cells (1997) (0)
Influence of FLG loss-of-function mutations in host-microbe interactions during atopic skin inflammation. (2022) (0)
A multiparameter flow cytometry platform for immunological biomarker discovery in psoriasis (2011) (0)
Immunological biomarker discovery in psoriasis using an advanced flow cytometry platform (2011) (0)
355 A human in vivo model of a cutaneous memory B cell immune response to skin antigen challenge (2016) (0)
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody (2008) (0)
Antigen specific immunotherapy: Quo vadis? (2005) (0)
Functional expression of the eotaxin receptor CCR3 in a subset of cutaneous T cell lymphoma (2001) (0)
The BRC Allergene Project: heritability of nickel allergy and genetic determinants (2013) (0)
IgG4 subclass antibodies: a novel immune escape mechanism in melanoma (2013) (0)
Increased CD4 and CD8 T-cell differentiation in elderly patients with melanoma (2012) (0)
The skin-homing V gamma 9V delta 2 T cell - a potential role in psoriasis? (2009) (0)
[Persistent facial swelling of uncertain origin]. (1998) (0)
Registrars’ Symposium (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Frank Oliver Nestle?

Frank Oliver Nestle is affiliated with the following schools:

Frank Oliver Nestle's Academic­Influence.com Rankings

Frank Oliver Nestle's Degrees

Why Is Frank Oliver Nestle Influential?

Frank Oliver Nestle's Published Works

Published Works

What Schools Are Affiliated With Frank Oliver Nestle?

Frank Oliver Nestle's AcademicInfluence.com Rankings